Read more about the article Rejuvenate Bio Started Treating Dogs: Why That’s a Win 
Scientist working with microscope in laboratory. Medical research

Rejuvenate Bio Started Treating Dogs: Why That’s a Win 

An investment perspective by Doug Sylvester, General Partner, Xcellerant Ventures, and Fund Manager, Jetstream Venture Fund  Jetstream recently invested in Rejuvenate Bio, a San Diego gene therapy company focused on…

Continue ReadingRejuvenate Bio Started Treating Dogs: Why That’s a Win